Medical archive note (2021): This report concerns an early investigation of a rare clotting disorder associated with adenovirus-vector COVID-19 vaccines, subsequently described as thrombosis with thrombocytopenia syndrome. Vaccine recommendations and clinical guidance evolved after this report; this historical summary is not current medical advice.
A rare blood clotting condition has occurred in some people after receiving the AstraZeneca COVID-19 vaccine. If the new research is correct, it could mean that blood clots could be easily treated.
— Read on www.npr.org/sections/coronavirus-live-updates/2021/03/21/979781065/european-scientists-zero-in-on-astrazeneca-blood-clot-link